News Verily developing AI-based heart disease test Deep learning AI analyses retinal images to determine heart disease risk.
News New heart attack data boost AZ’s Brilinta A new sub-analysis of data from a phase 3 trial shows AstraZeneca’s Brilinta cuts the risk of cardiovascular death by 29% in high risk patients.
News Daiichi Sankyo anticoagulant gains EU label boost Label gives guidance in use when restoring normal heart rhythm
News AliveCor and Mayo Clinic collaborate on heart screening tech New tool will help screen for Long QT syndrome to prevent sudden deaths.
Views & Analysis The Virtual Valve: improving treatment decisions for aortic ... How can a virtual reality heart aid in the treatment of a common heart condition?
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
